Mingyi Zhizao Secures $14 Million to Scale Gene Sequencing Platform and Production
Shenzhen Mingyi Zhizao Technology Co., Ltd, a Chinese company specializing in the gene sequencing industry,...
Finance
Zelgen Biopharmaceuticals Partners with Grand Life Sciences for Exclusive Marketing of Recombinant Human Thrombin
Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA: 688266) has announced an exclusive marketing promotion service agreement...
Sanofi Eyes Blockbuster Potential with 12 Pipeline Assets, Projects EUR 10 Billion in Annual Sales by 2030
Sanofi (NASDAQ: SNY) this week outlined its growth potential for the 2024 to 2025 period,...
Hisilicon Medical Technology Secures Nearly RMB 100 Million in Series A Funding
Guangdong Hisilicon Medical Technology Co., Ltd., a China-based firm, has successfully raised nearly RMB 100...
J&J Forecasts 5-7% CAGR Through 2030, Driven by Innovative Medicine and Device Growth
Johnson & Johnson (J&J; NYSE: JNJ) has presented an update on its business strategy, pipeline,...
China’s Betta Pharmaceuticals Advances CFT8919 for EGFR-Mutated NSCLC After NMPA Approval
Betta Pharmaceuticals Co., Ltd (SHE: 300558), a Chinese pharmaceutical company, has announced that it has...
Abbisko Therapeutics Strikes Licensing Deal with Merck KGaA for CSF-1R Inhibitor Pimicotinib
Abbisko Therapeutics Co., Ltd (HKG: 2256), a Shanghai-based biotechnology company, has announced a licensing agreement...
Aspen Pharmacare Holdings to Boost China Presence with Full Acquisition of Sandoz’s Subsidiary
Aspen Pharmacare Holdings (JSE: APN), a South Africa-based pharmaceutical company, is poised to enhance its...
SanegeneBio Secures Over USD 80 Million in Series A+ Funding to Advance RNAi Therapeutics
SanegeneBio, a Suzhou-based developer of RNA interference (RNAi) therapeutics, has successfully raised over USD 80...
Bosscome Science & Technology Secures Series A Funding for Precision Medical Navigation Systems
Bosscome Science & Technology, a Chongqing-based developer of integrated optical and magnetic navigation systems, has...
Taihe Weiye Biotechnology Secures RMB 300 Million in Series A+ Financing to Expand Production
Chengdu Taihe Weiye Biotechnology Co., Ltd, a Chinese developer of protected amino acids drugs, has...
Bayer Faces Backlash After Bond Sale Preceding Late-Stage Pipeline Failure
German pharmaceutical giant Bayer (ETR: BAYN) is facing investor and analyst scrutiny following its issuance...
Beijing QL Biopharmaceutical Boosts Pipeline with RMB 200 Million Series B+ Round
Beijing QL Biopharmaceutical Co., Ltd., a Chinese biopharmaceutical company, has reportedly secured nearly RMB 200...
OrbusNeich Medical Group to Acquire Majority Stake in Indonesian Distributor PT Revass Utama Medika
OrbusNeich Medical Group Ltd (HKG: 6929), a Wholly Owned Foreign Enterprise (WOFE) specializing in vascular...
Broncus Medical and Hangzhou Norchant Terminate Licensing Agreement with Cancellation Fee
Broncus Medical Inc., (HKG: 2216) a provider of lung disease precision intervention solutions with operations...
AbbVie Sues to Protect Rinvoq from Generic Competition in the US Market
AbbVie (NYSE: ABBV) has initiated legal action in the US to safeguard its blockbuster drug...
Zhejiang Huanqing Medical Technology Secures Series A Financing for Heart Failure Innovations
Zhejiang Huanqing Medical Technology Co., Ltd, a Chinese specialist in heart failure solutions, has reportedly...
True Health Secures Over RMB 100 Million in Series B+ Financing for Surgical Robot Development
True Health, a Guangdong-based surgical robot developer backed by Gree Group, has reportedly raised over...
Bayer Halts Late-Stage Trial for Asundexian After Underperformance
Germany-headquartered Bayer (ETR: BAYN) announced the termination of a late-stage trial for its antithrombotic candidate...
Dizal Pharmaceutical and Wuxi Gaofa Investment to Establish Joint Venture for Auto-Immune Disease Treatments
China-based AstraZeneca (AZ, NASDAQ: AZN) spin-out, Dizal Pharmaceutical Co., Ltd (SHA: 688192), has entered into...